US Patent 11939389 BCMA chimeric antigen receptors and uses thereof
Patent 11939389 was granted and assigned to Novartis on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+85 properties)
Article (+414 characters)
US Patent 11939389 BCMA chimeric antigen receptors and uses thereof
Article
Patent abstract
The invention provides compositions and methods for treating diseases associated with expression of BCMA. The invention also relates to chimeric antigen receptor (CAR) specific to BCMA, vectors encoding the same, and recombinant T cells comprising the BCMA CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises a BCMA binding domain.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Aida Abujoub0
Brian Holmberg0
Chonghui Zhang0
Connie Hong0
Dexiu Bu0
John Blankenship0
Lu Huang0
Tony Fleming0
Date of Patent
March 26, 2024
0Patent Application Number
181709690
Date Filed
February 17, 2023
0Patent Citations
0
Patent Primary Examiner
Find more entities like US Patent 11939389 BCMA chimeric antigen receptors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
